Stock listing

CGS Stock Price, News, Filings & Events — Cogstate Ltd

Selected listing: CGS · ASX · AUD · AU

This page tracks Cogstate Ltd's CGS:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CGS:ASX. CGS:ASX is the stock-level entry point for investors researching Cogstate Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cogstate Ltd is a public company listed on the Australian market under the ticker CGS, with a market capitalization of approximately AUD 305.46 million. The company specializes in cognitive assessment technology, providing solutions for clinical trials and healthcare settings. Cogstate aims to enhance the understanding of cognitive function through its innovative products and services.

CGS:ASXAUDAUUpdated August 28, 2026
Cogstate Ltd logo
Ticker
CGS:ASX
Asset type
Stock
Market cap
$391.2M
Sector
Commercial Services
Industry
Miscellaneous Commercial Services
Exchange
ASX
Currency
AUD

Cogstate Ltd CGS:ASX stock context

This page tracks Cogstate Ltd's CGS:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CGS:ASX. CGS:ASX is the stock-level entry point for investors researching Cogstate Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cogstate Ltd is a public company listed on the Australian market under the ticker CGS, with a market capitalization of approximately AUD 305.46 million. The company specializes in cognitive assessment technology, providing solutions for clinical trials and healthcare settings. Cogstate aims to enhance the understanding of cognitive function through its innovative products and services.

Latest news from Cogstate Ltd

All Cogstate Ltd news →

Cogstate Ltd earnings calls

Research Cogstate Ltd

Alternate listings